ReviewClinical and molecular hepatology2026

Steatotic liver disease: non-invasive assessment and biomarkers across metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction-associated steatotic liver disease with moderate alcohol consumption and alcohol-associated liver disease.

Monica Tincopa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.